PALB2 and cancer: Notably, 14% (3/21) of the identified breast cancer affected BRCA1/2 carriers and 25% (4/16) of the PALB2 carriers were diagnosed with another cancer by the time of last follow-up, and four of those were in the female reproductive system (uterus, ovaries, and two cervical cancers).